Reteplase (18mg)
Retefuse 18 mg Injection is used in the treatment of heart attack.
1 Injection in 1 packet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Retefuse 18 mg Injection is a thrombolytic medication. It works by dissolving the harmful blood clots in the blood vessels. This restores the blood flow to the affected tissue, thereby preventing tissue death and improving outcomes.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Retefuse 18 mg Injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Retefuse 18 mg Injection is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Not relevant, as Retefuse 18 mg Injection is intended for use in hospitalised patients.
Retefuse 18 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Retefuse 18 mg Injection may be needed. Please consult your doctor.
Use of Retefuse 18 mg Injection is not recommended in patients with severe kidney disease.
Retefuse 18 mg Injection should be used with caution in patients with liver disease. Dose adjustment of Retefuse 18 mg Injection may be needed. Please consult your doctor.
Use of Retefuse 18 mg Injection is not recommended in patients with severe kidney disease.
